T. Rowe Price Associates’s Thermo Fisher Scientific TMO Stock Holding History

T. Rowe Price Associates’s Portfolio TMO Stock Details TMO Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.25B	Sell	5,558,659 -3,746,173	-40%	-$1.52B	0.26%	73
2025 Q1	$4.63B	Sell	9,304,832 -1,611,792	-15%	-$802M	0.57%	25
2024 Q4	$5.68B	Sell	10,916,624 -56,433	-0.5%	-$29.4M	0.65%	19
2024 Q3	$6.79B	Buy	10,973,057 +1,047,687	+11%	+$648M	0.78%	15
2024 Q2	$5.49B	Sell	9,925,370 -129,251	-1%	-$71.5M	0.66%	22
2024 Q1	$5.84B	Buy	10,054,621 +156,675	+2%	+$91.1M	0.72%	18
2023 Q4	$5.25B	Sell	9,897,946 -240,159	-2%	-$127M	0.71%	21
2023 Q3	$5.13B	Buy	10,138,105 +1,018,758	+11%	+$516M	0.75%	18
2023 Q2	$4.76B	Buy	9,119,347 +532,715	+6%	+$278M	0.66%	23
2023 Q1	$4.95B	Sell	8,586,632 -537,025	-6%	-$310M	0.74%	22
2022 Q4	$5.02B	Buy	9,123,657 +161,344	+2%	+$88.9M	0.81%	19
2022 Q3	$4.55B	Sell	8,962,313 -3,784,504	-30%	-$1.92B	0.75%	20
2022 Q2	$6.93B	Sell	12,746,817 -1,784,259	-12%	-$969M	0.88%	13
2022 Q1	$8.58B	Buy	14,531,076 +1,460,532	+11%	+$863M	0.87%	12
2021 Q4	$8.72B	Sell	13,070,544 -106,205	-0.8%	-$70.9M	0.78%	19
2021 Q3	$7.53B	Sell	13,176,749 -140,002	-1%	-$80M	0.71%	20
2021 Q2	$6.72B	Buy	13,316,751 +2,133,690	+19%	+$1.08B	0.62%	26
2021 Q1	$5.1B	Sell	11,183,061 -1,379,329	-11%	-$629M	0.51%	30
2020 Q4	$5.84B	Sell	12,562,390 -1,413,237	-10%	-$658M	0.6%	27
2020 Q3	$6.17B	Sell	13,975,627 -627,594	-4%	-$277M	0.71%	20
2020 Q2	$5.29B	Sell	14,603,221 -1,876,897	-11%	-$680M	0.67%	24
2020 Q1	$4.67B	Buy	16,480,118 +178,135	+1%	+$50.5M	0.74%	25
2019 Q4	$5.3B	Sell	16,301,983 -772,368	-5%	-$251M	0.69%	27
2019 Q3	$4.97B	Sell	17,074,351 -64,974	-0.4%	-$18.9M	0.7%	24
2019 Q2	$5.03B	Buy	17,139,325 +395,830	+2%	+$116M	0.71%	19
2019 Q1	$4.58B	Buy	16,743,495 +996,962	+6%	+$273M	0.67%	24
2018 Q4	$3.52B	Buy	15,746,533 +1,551,118	+11%	+$347M	0.6%	30
2018 Q3	$3.46B	Buy	14,195,415 +2,555,183	+22%	+$624M	0.51%	36
2018 Q2	$2.41B	Sell	11,640,232 -1,189,163	-9%	-$246M	0.37%	57
2018 Q1	$2.65B	Buy	12,829,395 +751,435	+6%	+$155M	0.42%	52
2017 Q4	$2.29B	Sell	12,077,960 -254,187	-2%	-$48.3M	0.37%	59
2017 Q3	$2.33B	Sell	12,332,147 -573,884	-4%	-$109M	0.4%	53
2017 Q2	$2.25B	Sell	12,906,031 -3,314,231	-20%	-$578M	0.4%	51
2017 Q1	$2.49B	Sell	16,220,262 -1,007,184	-6%	-$155M	0.47%	43
2016 Q4	$2.43B	Sell	17,227,446 -5,729,417	-25%	-$808M	0.48%	44
2016 Q3	$3.65B	Buy	22,956,863 +603,695	+3%	+$96M	0.73%	18
2016 Q2	$3.3B	Sell	22,353,168 -1,230,660	-5%	-$182M	0.7%	27
2016 Q1	$3.34B	Sell	23,583,828 -1,510,915	-6%	-$214M	0.71%	24
2015 Q4	$3.56B	Buy	25,094,743 +1,287,436	+5%	+$183M	0.75%	22
2015 Q3	$2.91B	Buy	23,807,307 +2,456,850	+12%	+$300M	0.65%	27
2015 Q2	$2.77B	Sell	21,350,457 -927,029	-4%	-$120M	0.57%	32
2015 Q1	$2.99B	Sell	22,277,486 -1,049,584	-4%	-$141M	0.62%	26
2014 Q4	$2.92B	Buy	23,327,070 +1,061,187	+5%	+$133M	0.62%	24
2014 Q3	$2.71B	Buy	22,265,883 +726,728	+3%	+$88.4M	0.59%	30
2014 Q2	$2.54B	Buy	21,539,155 +2,060,498	+11%	+$243M	0.55%	31
2014 Q1	$2.34B	Sell	19,478,657 -6,291,231	-24%	-$756M	0.53%	37
2013 Q4	$2.87B	Buy	25,769,888 +743,021	+3%	+$82.7M	0.66%	20
2013 Q3	$2.31B	Sell	25,026,867 -946,410	-4%	-$87.2M	0.58%	27
2013 Q2	$2.2B	Buy	+25,973,277	New	+$2.2B	0.59%	29